Form 4: Evolus Inc. Officer Rui Avelar Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Rui Avelar, Chief Medical Officer & Head of Research and Development at Evolus, Inc., sold 27,603 shares of common stock on March 19, 2024, to cover tax withholding obligations related to Restricted Stock Units.
Summary
- On March 19, 2024, Rui Avelar, an officer at Evolus, Inc., sold 27,603 shares of common stock.
- The sale was mandated by the Issuer to cover tax withholding obligations related to Restricted Stock Unit Agreements.
- The shares were sold at a weighted average price of $13.9242, with individual trades ranging from $13.555 to $14.12.
- Following the transaction, Avelar still beneficially owns 372,288 shares of Evolus, Inc. common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the sale was to cover tax obligations and doesn't necessarily reflect a negative outlook on the company.
Industry Context
Sales by company officers are a normal part of corporate governance. It is important to consider the context of the sale, in this case, it was to cover tax obligations.
Stakeholder Impact
- The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 03/19/2024 | Date of transaction: Rui Avelar sold shares of Evolus, Inc. common stock. |
| 03/21/2024 | Date of report: Form 4 filing date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.